SECsense Logo

Cartesian Therapeutics 8-K Filing: Key Insights & SEC Compliance

$RNAC
Form 8-K
Filed on: 2025-01-13
Source
Cartesian Therapeutics 8-K Filing: Key Insights & SEC Compliance

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Cartesian Therapeutics, Inc.
  • CIK: 0001453687
  • IRS Employer Identification Number (EIN): 26-1622110
  • Address: 7495 New Horizon Way, Frederick, MD 21703
  • Phone Number: 301-348-8698
  1. Filing Details:
  • Form Type: 8-K (a report used to disclose unscheduled material events or corporate changes)
  • Filing Date: January 13, 2025
  • Period Covered: The report is for a single day, January 13, 2025.
  1. Securities Information:
  • Type of Security: Common Stock
  • Par Value: $0.0001
  • Stock Exchange: NASDAQ
  • Ticker Symbol: RNAC
  1. Contextual Information:
  • The report is filed under the SEC's XBRL (eXtensible Business Reporting Language) format, which indicates that it is structured for electronic filing and analysis.

Summary

This section of the financial report pertains to Cartesian Therapeutics, Inc. and includes essential information about the company's filing, such as the type of report (8-K), the date of filing, and details regarding its common stock. The report appears to be filed in a digital format, indicating compliance with SEC regulations for transparency and accessibility.